Live Breaking News & Updates on Bridgewest Group Portfolio

Stay updated with breaking news from Bridgewest group portfolio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

LumaCina announces availability of Oral Morphine pain medication for New Zealanders

LumaCina announces availability of Oral Morphine pain medication for New Zealanders
fnarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fnarena.com Daily Mail and Mail on Sunday newspapers.

United States , Western Australia , New Zealand , Masood Tayebi , Cyrusk Mirsaidi , Bridgewest Group Portfolio Company , Bridgewest Group , Bridgewest Perth Pharma , Oral Morphine , Bridgewest Perth , Founding Partner , Pfizer Perth , Bridgewest Group Portfolio ,

LumaCina announces availability of Oral Morphine pain medication for New Zealanders

LumaCina announces availability of Oral Morphine pain medication for New Zealanders
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New Zealand , United States , Western Australia , Cyrusk Mirsaidi , Masood Tayebi , Bridgewest Group Portfolio Company , Bridgewest Group , Bridgewest Perth Pharma , Oral Morphine , Bridgewest Perth , Founding Partner , Pfizer Perth , Bridgewest Group Portfolio ,

Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit

MIAMI and PERTH, Australia, April 26, 2023 /PRNewswire/ Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, establishes LumaCina business unit under Bridgewest Perth Pharma in Perth, Australia. The newly created business leverages the acclaimed team and production facility recently acquired by Bridgewest Group from Pfizer (Perth) Pty Ltd, a subsidiary of Pfizer, Inc., plus the addition of newly expanded capabilities, most notably, R & D. LumaCina will commercialize sterile injectable drugs in global markets and is actively expanding its portfolio through increased production under LumaCina branding. "Our recent acquisitions in Australia are a reflection of the importance we place in meeting the growing demand for high quality pharmaceuticals, both regionally, and globally. LumaCina increases our ability to help healthcare professionals readily access quality sterile injectable medicines w ....

Western Australia , New Zealand , United States , Jenny Bourbiel , Jon Kafer , Masood Tayebi , Ian Wisenberg , Life Sciences , Perth Pharma Pty Ltd , Pfizer Inc , Bridgewest Group Portfolio Company , Bridgewest Group , Pfizer Perth Pty Ltd , Bridgewest Perth Pharma , Pty Ltd , Chief Commercial Officer , Bridgewest Perth Pharma Pty Ltd , Pfizer Perth , Chief Executive Officer , Bridgewest Group Portfolio , Media Contact , Miami And Perth , April 26 , 023 Prnewswire Global Private Investment Firm , Bridgewest Group , Ecognized For Developing Innovative Companies In Life Sciences ,